Literature DB >> 34021434

Abnormal pulmonary flow is associated with impaired right ventricular coupling in patients with COPD.

Ani Oganesyan1, Alexander Hoffner-Heinike2, Alex J Barker3, Benjamin S Frank1, D Dunbar Ivy1, Kendall S Hunter4, Max B Mitchell5, Stephen M Humphries6, Brett E Fenster6, Michal Schäfer1.   

Abstract

Cor Pulmonale or right ventricular (RV) dysfunction due to pulmonary disease is an expected complication of COPD resulting primarily from increased afterload mediated by chronic alveolar hypoxemia and resulting hypoxic pulmonary vasoconstriction. Early detection of elevated RV afterload has been previously demonstrated by visualization of abnormal flow patterns in the proximal pulmonary arteries. Prior analysis of helicity in the pulmonary arteries in pulmonary hypertension patients has demonstrated a strong association between helicity and increased RV afterload. However, these flow hemodynamics have yet to be fully explored in patients with COPD. We hypothesized that patients with COPD will have abnormal pulmonary flow as evaluated by 4D-Flow MRI and associated with RV function and pulmonary arterial stiffness. Patients with COPD (n = 15) (65 years ± 6) and controls (n = 10) (58 years ± 9) underwent 4D-Flow MRI to calculate helicity. The helicity was calculated in the main pulmonary artery (MPA) and along the RV outflow tract (RVOT)-MPA axis. Main pulmonary arterial stiffness was measured using the relative area change (RAC). We found COPD patients had decreased helicity relative to healthy controls in the MPA (19.4 ± 7.8vs 32.8 ± 15.9, P = 0.007) and reduced helicity along the RVOT-MPA axis (33.2 ± 9.0 vs 43.5 ± 8.3, P = 0.010). Our investigation indicates a strong association between helicity along the MPA-RV outflow tract axis and RV function and suggests that 4D-Flow MRI might be a sensitive tool in evaluating RV-pulmonary arterial coupling in COPD.

Entities:  

Keywords:  4-D flow; COPD; Cor pulmonale; MRI

Year:  2021        PMID: 34021434     DOI: 10.1007/s10554-021-02285-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  25 in total

1.  Pulmonary Arteries and Microcirculation in COPD With Pulmonary Hypertension: Bystander or Culprit?

Authors:  Rubin M Tuder; Carlyne D Cool
Journal:  Chest       Date:  2019-07       Impact factor: 9.410

Review 2.  Treating Hypertension in Chronic Obstructive Pulmonary Disease.

Authors:  Shannon W Finks; Mark J Rumbak; Timothy H Self
Journal:  N Engl J Med       Date:  2020-01-23       Impact factor: 91.245

3.  Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study.

Authors:  Javier Sanz; Ana García-Alvarez; Leticia Fernández-Friera; Ajith Nair; Jesús G Mirelis; Simonette T Sawit; Sean Pinney; Valentin Fuster
Journal:  Heart       Date:  2011-09-13       Impact factor: 5.994

Review 4.  Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine.

Authors:  Kimberly J Dunham-Snary; Danchen Wu; Edward A Sykes; Amar Thakrar; Leah R G Parlow; Jeffrey D Mewburn; Joel L Parlow; Stephen L Archer
Journal:  Chest       Date:  2016-09-16       Impact factor: 9.410

Review 5.  Four-dimensional Flow MRI: Principles and Cardiovascular Applications.

Authors:  Arshid Azarine; Philippe Garçon; Audrey Stansal; Nadia Canepa; Giorgios Angelopoulos; Stephane Silvera; Daniel Sidi; Véronique Marteau; Marc Zins
Journal:  Radiographics       Date:  2019-03-22       Impact factor: 5.333

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

Review 7.  The role of pulmonary arterial stiffness in COPD.

Authors:  Jonathan R Weir-McCall; Allan D Struthers; Brian J Lipworth; J Graeme Houston
Journal:  Respir Med       Date:  2015-06-12       Impact factor: 3.415

8.  Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations.

Authors:  Michal Schäfer; Alex J Barker; Vitaly Kheyfets; Kurt R Stenmark; James Crapo; Michael E Yeager; Uyen Truong; J Kern Buckner; Brett E Fenster; Kendall S Hunter
Journal:  J Am Heart Assoc       Date:  2017-12-20       Impact factor: 5.501

Review 9.  Changing the burden of COPD mortality.

Authors:  David M Mannino; Victor A Kiriz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  4D flow cardiovascular magnetic resonance consensus statement.

Authors:  Petter Dyverfeldt; Malenka Bissell; Alex J Barker; Ann F Bolger; Carl-Johan Carlhäll; Tino Ebbers; Christopher J Francios; Alex Frydrychowicz; Julia Geiger; Daniel Giese; Michael D Hope; Philip J Kilner; Sebastian Kozerke; Saul Myerson; Stefan Neubauer; Oliver Wieben; Michael Markl
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-10       Impact factor: 5.364

View more
  1 in total

1.  Effects of Cardiopulmonary Rehabilitation Promotion Mode Intervention Combined with Oxygen Therapy on Cardiopulmonary Function and Blood Gas Analysis Indexes of COPD Patients with Cor Pulmonale.

Authors:  Xiangmei Xie; Huihong Chen; Jie Fan; Qin Min; Donghua Fan
Journal:  J Healthc Eng       Date:  2022-03-26       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.